Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Pathology and disease mechanisms in different stages of multiple sclerosis.
Small Molecules in Stem Cell Research.
Natalizumab exerts a suppressive effect on surrogates of B cell function in blood and CSF.
Effects of cannabinoids on LPS-stimulated inflammatory mediator release from macrophages: involvement of eicosanoids.
Phenytoin: an old but effective antiarrhythmic agent for the suppression of ventricular tachycardia.
Ion Channel Modulation as a Therapeutic Approach in Multiple Sclerosis.
Diffusion-weighted imaging characteristics of biopsy-proven demyelinating brain lesions.
Cognitive Impairment in Multiple Sclerosis.
Treatment with natalizumab in relapsing-remitting multiple sclerosis patients induces changes in inflammatory mechanism.
Intrauterine environment and multiple sclerosis: a population- based case-control study.
Cutting Edge: TNF Receptor-Associated Factor 4 Restricts IL-17-Mediated Pathology and Signaling Processes.
Acute hypercalcemia following excessive calcium supplementation in a dehydrated patient with progressive multiple sclerosis: vitamin d supplementation is a red herring-reply.
Resveratrol effects on astrocyte function: Relevance to neurodegenerative diseases.
Selective JAK1 inhibitor and selective Tyk2 inhibitor patents.
Motivational interviewing may improve exercise experience for people with multiple sclerosis: A small randomized trial.
Fingolimod protects cultured cortical neurons against excitotoxic death.
Validation of patient determined disease steps (PDDS) scale scores in persons with multiple sclerosis.
Contribution of cortical lesion subtypes at 7T MRI to physical and cognitive performance in MS.
Effects of early IL-17A neutralization on disease induction in a primate model of experimental autoimmune encephalomyelitis.
Neuroprotection With Riluzole Patients With Early Multiple Sclerosis
Post-Partum Treatment With Immunoglobulin Does Not Prevent Relapses of Multiple Sclerosis in the Mother.
The nervous system's potential role in multiple sclerosis associated bone loss.
Detection of anti-aquaporin-4 antibodies in neuromyelitis optica: comparison of tissue-based and cell-based indirect immunofluorescence assays and ELISA.
Longitudinal Penalized Functional Regression for Cognitive Outcomes on Neuronal Tract Measurements.
Dual effects of daily FTY720 on human astrocytes in vitro: relevance for neuroinflammation.
Pages
« first
‹ previous
…
220
221
222
223
224
225
226
227
228
…
next ›
last »